Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

22 Jun 2017 10:51

RNS Number : 8776I
Ubisense Group PLC
22 June 2017
 

22 June 2017

 

Ubisense Group Plc

Directors' Dealings

Ubisense Group plc (LSE:UBI, "Company" or "Ubisense") received notification on 21 June 2017 from Kestrel Partners LLP ("Kestrel") that on 21 June 2017 it acquired, on behalf of its discretionary clients, 115,000 ordinary shares of 2p each ("Shares") in the Company at a price of £0.37 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr Scott is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ubisense.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 15,915,493 Shares in the Company.

Of the Shares purchased, 97,750 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,855,785 Shares in the Company. The remaining 17,250 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Scott has no beneficial interest, who, following this transaction, hold a further 4,174,708 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 16,030,493 Shares in the Company, which represents approximately 28.69% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,855,785

21.22%

Indirect

JIM Nominees Limited

1,306,095

2.34%

Indirect

Bank of New York Nominees Ltd

2,868,613

5.13%

 

For further information contact:

 

Ubisense Group PLCPeter Harverson

Tim Gingell

 

+44 (0) 1223 535 170

Numis Securities LimitedSimon Willis

Jamie Lillywhite

Toby Adcock

+44 (0) 20 7260 1000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGZVLZGGNZG
Date   Source Headline
30th May 20249:33 amPRNForm 8.3 - IQGeo Group Plc
30th May 20249:29 amRNSForm 8.3 - IQGeo Group Plc
29th May 20241:08 pmRNSUpdate on LOI given by Charles Stanley & Co Ltd
29th May 202410:24 amRNSForm 8.3 - IQGeo Group plc
29th May 202410:20 amRNSForm 8.5 (EPT/NON-RI)
28th May 20243:25 pmRNSForm 8.3 - IQGeo Group plc
28th May 20249:31 amRNSForm 8.5 (EPT/NON-RI)
24th May 20243:25 pmRNSForm 8.3 - IQGeo Group plc
24th May 20243:11 pmRNSForm 8.3 - IQGEO GROUP PLC
24th May 20241:30 pmRNSForm 8.5 (EPT/NON-RI)
24th May 202412:00 pmRNSForm 8.3 - IQGeo Group plc
24th May 202411:30 amRNSUpdate on LOI given by Charles Stanley & Co Ltd
24th May 202410:07 amRNSForm 8.3 - IQGeo Group plc
23rd May 20243:40 pmRNSForm 8.3 - IQGeo Group plc
23rd May 20243:25 pmRNSForm 8.3 - IQGeo Group plc
23rd May 202411:57 amRNSForm 8.3 - IQGeo Group plc
23rd May 202410:54 amPRNForm 8.3 - IQGEO GROUP PLC
22nd May 20244:47 pmRNSUpdate on LOI given by Charles Stanley & Co Ltd
22nd May 202412:10 pmRNSForm 8.3 - IQGeo Group plc
22nd May 202410:54 amRNSForm 8.3 - IQGeo plc
22nd May 202410:31 amRNSForm 8.3 - IQGeo Group plc
22nd May 20247:45 amRNSForm 8.5 (EPT/NON-RI)
21st May 20246:30 pmRNSForm 8 (OPD)
21st May 20245:47 pmRNSForm 8.3 - IQGeo Group plc
21st May 202411:22 amRNSForm 8.3 - IQGeo Group plc
21st May 202410:46 amRNSForm 8.5 (EPT/NON-RI)
20th May 20242:00 pmRNSHolding(s) in Company
20th May 20241:46 pmRNSForm 8.3 - Iqgeo Group plc
20th May 202411:27 amRNSForm 8.5 (EPT/NON-RI)
17th May 20244:30 pmRNSRule 2.9 Announcement and TVR
17th May 20243:07 pmRNSForm 8.3 - IQGEO Group Plc
17th May 20249:09 amRNSForm 8.5 (EPT/NON-RI)
16th May 202412:56 pmPRNForm 8 - IQGeo Group Plc
16th May 202412:24 pmRNSForm 8.3 - IQGeo Group plc
16th May 202411:31 amRNSForm 8.5 (EPT/NON-RI)
15th May 20244:45 pmRNSResult of Annual General Meeting
15th May 20243:47 pmGNWForm 8.3 - [IQGEO GROUP PLC - Opening Disclosure - 14 05 2024] - (CGAML)
15th May 20243:31 pmPRNForm 8.3 - IQGeo Group Plc
15th May 202412:44 pmRNSForm 8.3 - IQGeo Group plc
15th May 202412:05 pmRNSForm 8.3 - IQGeo Group plc
15th May 202411:41 amRNSForm 8.3 - [IQGeo Group plc ]
15th May 202411:09 amRNSForm 8.3 - IQGeo Group PLC
15th May 202410:47 amRNSForm 8.5 (EPT/NON-RI)
15th May 202410:00 amPRNForm 8.3 - IQGeo Group plc
15th May 20249:10 amRNSRule 2.9 Announcement and TVR
14th May 20243:38 pmRNSForm 8.3 - IQGEO Group plc
14th May 202411:55 amRNSForm 8.3 - IQGeo Group plc
14th May 202410:28 amRNSRecommended Cash Acquisition
3rd May 20247:00 amRNSTotal Voting Rights
30th Apr 202411:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.